Wednesday, October 21, 2020

Specific Antibody In Blood May Be Biomarker Of Kidney Disease In Lupus Patients

Must Read

BARACK OBAMA : AMERICA WANTS ME BACK FOR A 3RD TERM

He was supposed to retire to a triumphant post-presidency. Then Trump happened. Now, as Jason Zengerle reports, Obama is...

Pennsylvania GOP Sen. Pat Toomey Won’t Run For Re-Election in 2022

Pennsylvania Republican Sen. Pat Toomey has announced that he will not run for reelection in 2022. “I will not be...

Barack Obama Reportedly Skeptical of Joe Biden’s 2020 White House Run

The presidential election is officially less than 30 days away. With that in mind, we thought it would be helpful...

Specific Antibody In Blood May Be Biomarker Of Kidney Disease In Lupus Patients

The presence of anti-ficolin-3 antibodies could be a biomarker to diagnose active lupus disease with kidney involvement, Ficolin-3 is important in the context of auto-immunity because it was first characterized in the blood of lupus patients as a target of autoantibodies. But the significance of this observation has, to date, not been investigated in detail.Researchers led by Dr. Chantal Dumestre-Pérard, of Université Grenoble Alpes in France, analyzed blood samples from 165 lupus patients and 48 healthy controls, and determined the levels of anti-ficolin-3 antibodies.

The researchers found treatment that the levels of anti-ficolin-3 antibodies correlated with SLEDAI scores. In other words, the higher the level of anti-ficolin-3 antibodies in a patient, the higher that patient’s SLEDAI score.They concluded in their study, “Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus,” that anti-ficolin-3 antibodies could be useful in helping to diagnose active nephritis in patients, but suggest that further studies are needed to confirm the diagnostic value of this potential biomarker.Lupus is characterized by the presence of autoantibodies in the blood that attack a patient’s own tissues and organs, resulting in systemic inflammation and damage.

They found a highly significant difference in the levels of anti-ficolin-3 antibodies between the two groups, with antibodies detected in the blood of 56 (34%) of the lupus patients. Importantly, the team saw that levels of anti-ficolin-3 antibodies were significantly higher in patients with active disease and this disesse nephritis (kidney inflammation) than in patients with active disease but no kidney involvement.To determine disease activity, researchers used the SLEDAI (systemic lupus erythematosus disease activity index score), which assesses clinical manifestations across an array of measures: seizure, psychosis, decreased mental function and other neurological problems, visual disturbance, hair loss, rash, muscle weakness, arthritis, blood vessel inflammation, mouth sores, chest pain that gets worse with deep breathing, inflammation of the pleura (tissue protecting the lungs) and pericardium (membrane surrounding the heart) and fever.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

BARACK OBAMA : AMERICA WANTS ME BACK FOR A 3RD TERM

He was supposed to retire to a triumphant post-presidency. Then Trump happened. Now, as Jason Zengerle reports, Obama is...

Pennsylvania GOP Sen. Pat Toomey Won’t Run For Re-Election in 2022

Pennsylvania Republican Sen. Pat Toomey has announced that he will not run for reelection in 2022. “I will not be running for reelection in 2022...

Barack Obama Reportedly Skeptical of Joe Biden’s 2020 White House Run

The presidential election is officially less than 30 days away. With that in mind, we thought it would be helpful to remind readers that despite...

LeBron James Walks Off Court With Time Left on Clock During NBA Finals

However, those who are watching got to see Los Angeles Lakers superstar LeBron James throw a hissy fit on Monday night after his team...

AOC Says Dems Must Consider Impeaching Trump, Barr To Stop Supreme Court Nomination

Impeachment would force the U.S. Senate to hold a trial at a time when it has precious few days left on its calendar to...
- Advertisement -

More Articles Like This